Biyomedikal Mühendisliği Bölümü Makale Koleksiyonu

Bu koleksiyon için kalıcı URI

Güncel Gönderiler

Listeleniyor 1 - 20 / 90
  • Öğe
    Synergistic advancements: Exploring MXene/graphene oxide and MXene/reduced graphene oxide composites for next-generation applications
    (Elsevier b.v., 2024) Iravani, Siavash; Zarepour, Atefeh; Nazarzadeh Zare, Ehsan; Makvandi, Pooyan; Khosravi, Arezoo; Zarrabi, Ali
    The exploration of MXene-graphene oxide (GO) and MXene-reduced GO (rGO) composites represents a significant leap forward in the development of advanced materials for next-generation applications. This review delves into the synergistic properties of MXene and GO, highlighting their combined potential to develop various technological fields. MXenes, with their unique two-dimensional structure and exceptional electrical conductivity, coupled with the remarkable mechanical strength and flexibility of GO, create composites with enhanced performance characteristics. These materials exhibit superior electrochemical properties, making them ideal candidates for energy storage devices such as supercapacitors and batteries. Additionally, their excellent thermal and mechanical properties open new avenues in the fields of electronics, sensors, and catalysis. This review seeks to explore the specific areas where MXene-(r)GO composites demonstrate exceptional promise, such as energy storage, sensing technologies, electromagnetic interference shielding, visible/infrared camouflages, and advanced materials development. These composites offer a promising pathway to address the growing demands for high-performance, multifunctional materials in various industrial sectors. This review aims to provide insights into the fundamental mechanisms driving the enhanced properties of MXene-(r)GO composites and to inspire further research and development in this exciting area of material science.
  • Öğe
    Sustained release investigation of curcumin and ciprofloxacin on coaxial electrospun nanocomposite scaffold of poly (3-hydroxybutyrate)-poly glycerol sebacate: an approach for skin regeneration
    (Springer nature, 2025) Hosseini, Seyed Mohammad Reza; Heydari, Parisa; Azadani, Reyhaneh Nasr; Iravani, Siavash; Zarrabi, Ali
    The utilization of biomaterial scaffolds may promote the regeneration of cutaneous wounds. The investigation focused on fabricating an innovative type of scaffold for skin tissue regeneration through the coaxial electrospinning technique. The scaffold consisted of two segments: the core layer accommodated a combination of polyglycerol sebacate (PGS) and curcumin (Cur), while the shell layer contained poly(3-hydroxybutyrate) (PHB) and ciprofloxacin (CIP). An evaluation was conducted on the physical and mechanical properties, drug release characteristics, and cellular responses of the scaffolds. The assessment revealed that the fiber diameters and porosity of PGS/PHB and PGS/PHB-Cur/CIP were measured at 400-480 nm and 83-86%, respectively. The transmission electron microscopy (TEM) findings exhibited distinct core and shell structures in the PGS/PHB-Cur/CIP specimens. The specific aspects of the PGS/PHB-Cur/CIP scaffold, such as its controlled degradation (below 50% over 21 days), sustained drug release behavior of Cur and CIP (over 5 days), and optimal strength attributes (stress strength similar to 0.104 MPa), differentiate it from traditional wound coverings. Specifically, the incorporation of CIP and Cur into the fiber configuration enhanced the viability and adhesion of cells, resulting in an appropriate morphology. Therefore, the coaxial PGS/PHB-Cur/CIP demonstrates a heightened potential for wound dressing application or as a skin substitute.
  • Öğe
    Ambient pressure dried graphene oxide-silica composite aerogels as pharmaceutical nanocarriers
    (Springer, 2025) Salihi, Elif Çalışkan; Zarrabi, Ali; Zarepour, Atefeh; Gürboğa, Merve; Hasan Niari Niar, Shalaleh; Özakpınar, Özlem Bingöl; Wang, Jiabin; Daştan, Havva; Khosravi, Arezoo; Šiller, Lidija
    Research on the production of graphene, its derivatives and composites has been enhanced in the past two decades. Graphene is well known for its exceptional physicochemical properties including extensive surface area, good biocompatibility, high loading capacity, and functionalization capability which make it an ideal candidate for drug delivery systems. When compared to the other nanomaterials, aerogels are relatively new materials characterized by their unparalleled porosities and extensive surface areas. The ability to carry drugs is crucial in drug delivery systems, and the large surface area of graphene coupled with the high porosity of aerogels presents a significant potential for use in this domain. In this study, graphene oxide-silica composite aerogel nanostructures were synthesized firstly, using the sol-gel method and ambient pressure drying technique which offer advantages in terms of both time and cost efficiency. Then, the formulation was also fabricated in the functionalized forms with sodium dodecyl sulfate, polyvinylpyrrolidone and ethylenediaminetetraacetic acid. Different physicochemical characteristics of these new materials were investigated using SEM/EDS, XRD, Raman spectroscopy, FTIR spectroscopy, TGA and DLS techniques. Drug loading tests were done using curcumin and methylene blue, while the biocompatibility of the nanocarriers was assessed through cell viability assay. Results of different tests confirmed the successful fabrication of the aerogels with different functionalizations, which had encapsulation capacity ranged between 20–90% and high biocompatibility after exposing with cells. Based on these promising results, this study confirms that aerogel-based platforms produced have potential to be used as nanocarriers for drug delivery systems. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
  • Öğe
    Biohybrid Micro/Nanorobots: Pioneering the Next Generation of Medical Technology
    (John Wiley and Sons Inc, 2024) Zarepour, Atefeh; Khosravi, Arezoo; Iravani, Siavash; Zarrabi, Ali
    Biohybrid micro/nanorobots hold a great potential for advancing biomedical research. These tiny structures, designed to mimic biological organisms, offer a promising method for targeted drug delivery, tissue engineering, biosensing/imaging, and cancer therapy, among other applications. The integration of biology and robotics opens new possibilities for minimally invasive surgeries and personalized healthcare solutions. The key challenges in the development of biohybrid micro/nanorobots include ensuring biocompatibility, addressing manufacturing scalability, enhancing navigation and localization capabilities, maintaining stability in dynamic biological environments, navigating regulatory hurdles, and successfully translating these innovative technologies into clinical applications. Herein, the recent advancements, challenges, and future perspectives related to the biomedical applications of biohybrid micro/nanorobots are described. Indeed, this review sheds light on the cutting-edge developments in this field, providing researchers with an updated overview of the current potential of biohybrid micro/nanorobots in the realm of biomedical applications, and offering insights into their practical applications. Furthermore, it delves into recent advancements in the field of biohybrid micro/nanorobotics, providing a comprehensive analysis of the current state-of-the-art technologies and their future applications in the biomedical field. © 2024 The Author(s). Advanced Healthcare Materials published by Wiley-VCH GmbH.
  • Öğe
    Precision Nanomedicine: Lapatinib-Loaded Chitosan-Gold Nanoparticles Targeting LINC01615 for Lung Cancer Therapy
    (Springer Science and Business Media Deutschland GmbH, 2025) Rezaei Aghdam, Hadi; Peymani, Maryam; Salehzadeh, Ali; Rouhi, Leila; Zarepour, Atefeh; Zarrabi, Ali
    Long non-coding RNAs (lncRNAs) play essential roles as oncogenic factors in cancer progression by influencing cell proliferation, apoptosis, and metastasis pathways. This study aims to investigate the expression changes of LINC01615 in prevalent cancers, explore its correlation with patient mortality rates, and introduce a novel therapeutic approach to reduce LINC01615 expression. Using The Cancer Genome Atlas (TCGA) data, the expression changes of LINC01615 in various cancers were analyzed, and its relationship with patient survival rates through Cox regression analysis weas assessed. Co-expressed pathways related to LINC01615 were identified via network analysis. Potential drugs to decrease LINC01615 expression were identified using the GSE38376 study. Besides, chitosan-coated nanoparticles were fabricated and functionalized with the identified drug, Lapatinib, to examine their effect on lung cancer cell lines and changes in LINC01615 expression. Our results indicated elevated LINC01615 expression in various common cancers, particularly in lung cancer, which was associated with poor prognosis in lung, breast, and kidney cancers. Co-expression network analysis suggested links to metastasis-related genes. Lapatinib, identified through GEO data, was found to modulate LINC01615 expression effectively. Chitosan-gold nanoparticles conjugated with Lapatinib significantly reduced LINC01615 expression in lung cancer cell lines while enhancing apoptosis rates. Therefore, these nanoparticles could be considered a promising therapeutic candidate for treating cancers with overexpression of LINC01615. Graphical Abstract: (Figure presented.) © The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists 2024.
  • Öğe
    Machine learning and experimental analyses identified miRNA expression models associated with metastatic osteosarcoma
    (Elsevier, 2024) Abedi, Samira; Behmanesh, Ali; Mazhar, Farid Najd; Bagherifard, Abolfazl; Sami, Sam Hajialiloo; Heidari, Negar; Hossein-Khannazer, Nikoo; Namazifard, Saina; Arki, Mandana Kazem; Shams, Roshanak; Zarrabi, Ali; Vosough, Massoud
    Osteosarcoma (OS), as the most common primary bone cancer, has a high invasiveness and metastatic potential, therefore, it has a poor prognosis. This study identified early diagnostic biomarkers using miRNA expression profiles associated with osteosarcoma metastasis. In the first step, we used RNA-seq and online microarray data from osteosarcoma tissues and cell lines to identify differentially expressed miRNAs. Then, using seven feature selection algorithms for ranking, the first-ranked miRNAs were selected as input for five machine learning systems. Using network analysis and machine learning algorithms, we developed new diagnostic models that successfully differentiated metastatic osteosarcoma from non-metastatic samples based on newly discovered miRNA signatures. The results showed that miR-34c-3p and miR-154-3p act as the most promising models in the diagnosis of metastatic osteosarcoma. Validation for this model by RT-qPCR in benign tissue and osteosarcoma biopsies confirmed the lower expression of miR-34c-3p and miR-154-3p in OS samples. In addition, a direct correlation between miR-34c-3p expression, miR-154-3p expression and tumor grade was discovered. The combined values of miR-34c-3p and miR-154-3p showed 90 % diagnostic power (AUC = 0.90) for osteosarcoma samples and 85 % (AUC = 0.85) for metastatic osteosarcoma. Adhesion junction and focal adhesion pathways, as well as epithelial-to-mesenchymal transition (EMT) GO terms, were identified as the most significant KEGG and GO terms for the top miRNAs. The findings of this study highlight the potential use of novel miRNA expression signatures for early detection of metastatic osteosarcoma. These findings may help in determining therapeutic approaches with a quantitative and faster method of metastasis detection and also be used in the development of targeted molecular therapy for this aggressive cancer. Further research is needed to confirm the clinical utility of miR-34c-3p and miR-154-3p as diagnostic biomarkers for metastatic osteosarcoma.
  • Öğe
    Sustainable nanomaterials for precision medicine in cancer therapy
    (Elsevier, 2024) Bigham, Ashkan; Zarepour, Atefeh; Khosravi, Arezoo; Iravani, Siavash; Zarrabi, Ali
    Sustainable nanomaterials have attracted much attention in the last decades in different applications mainly to minimize harm to environment by using renewable resources. One of those areas is precision medicine for cancer therapy, offering tailored solutions for targeted drug delivery, cancer immunotherapy, imaging/biosensing, and therapy monitoring. Recent trends in bio- and nanomedicine have focused on developing biocompatible and biodegradable multifunctional nanocarriers that enhance drug delivery efficiency while minimize systemic toxicity. Fabricating sustainable nanomaterials with smart functionalities, such as stimuli-responsive behavior and targeted drug release mechanisms, holds great potential for improving the efficacy of therapy with more desirable outcomes. However, challenges persist in ensuring the biosafety, targeting efficiency, and specificity of these nanomaterials; also, clinical translation studies, optimizing scalability, and cost-effectiveness in production processes need to be addressed. The primary purpose of this review is to examine the recent advancements in sustainable nanomaterials for precision medicine in targeted cancer therapy via summarizing the progress made in this field. In addition, we mentioned about the crucial challenges related to these innovative solutions, such as ensuring the safety and sustainability of nanomaterials. Moreover, by exploring the future perspectives of this technology, we hope to provide insights into the direction of developments in sustainable nanomaterials for precision medicine, particularly in the context of targeted cancer therapy.
  • Öğe
    Preparation and characterization of PBS (polybutylene succinate) nanoparticles containing cannabidiol (CBD) for anticancer application
    (Elsevier, 2024) Freire, Natalia Freitas; Cordani, Marco; Aparicio-Blanco, Juan; Sanchez, Ana Isabel Fraguas; Dutra, Luciana; Pinto, Martina C. C.; Zarrabi, Ali; Pinto, Jose Carlos; Velasco, Guillermo; Fialho, Rosana
    Cannabidiol (CBD), a major constituent of Cannabis sativa, has demonstrated a broad range of therapeutic properties in human studies. Notably, CBD has shown anticancer activity in preclinical cancer models. However, its low water solubility poses challenges for bioavailability, necessitating the development of drug delivery systems to enhance its efficacy. This study aimed to create CBD-loaded Poly (butylene succinate) (PBS) nanoparticles and evaluate their effectiveness in in vitro cancer models. The nanoparticles, with an average size of 175 nm, were produced using a modified double emulsion/solvent evaporation technique. The release profile of CBD from the nanoparticles exhibited an initial rapid release followed by a slower sustained release. Cytotoxicity assays demonstrated that the CBD-PBS nanoparticles retained the anticancer effects of free CBD, selectively reducing the viability of cancer cell lines without affecting non -transformed fibroblasts. Additionally, the nanoformulation modulated key cellular pathways, as indicated by decreased AKT phosphorylation and increased LC3-II levels, suggesting that the encapsulated CBD preserved its ability to induce autophagy-mediated cell death in cancer cells. The nanoformulation also effectively inhibited cell migration in highly invasive prostate cancer cells, mirroring the effects of free CBD, while not impacting the migration of non -tumoral fibroblasts. These results underscore the therapeutic potential of this CBD nanoformulation, setting the stage for further in vivo investigations.
  • Öğe
    The apoptotic effect of garlic (Allium sativum) derived SEVs on different types of cancer cell lines in vitro
    (Tubitak scientific & technological research council Turkey, 2024) Ünsal, Naz; Koçak, Polen; Yılmaz, Hazal; Şahin, Fikrettin; Canpolat, Merve Yıldırım
    Background/aim: Small extracellular vesicles (SEVs) are known to have an impact on the physiological conditions of target cells, are a critical component of cell -to -cell communication, and have been implicated in a variety of diseases. Although it has been proposed that edible plant -derived nanoparticles have an effect on communication with mammalian cells, the influence of these nanoparticles on cancer cell development has yet to be explored. Materials and methods: In order to characterize small extracellular vesicles obtained from garlic, specific SEV surface markers, antibodies, and size detections were identified using scanning electron microscopy and nanoparticle tracking analysis. Human hepatoma (Hep3B), human neuroblastoma (SH-SY5Y), human pancreatic adenocarcinoma (Panc-1a), human glioblastoma (U87), prostate cancer (PC -3), and human umbilical vein endothelial (HUVEC) cell lines were treated with garlic SEVs to examine their anticancer properties. Results: Annexin V FITC/PI staining for apoptosis, mRNA, and protein expression levels via RT-PCR and ELISA indicated that garlic SEVs triggered apoptosis by activating the intrinsic pathway. Our findings support the idea that SEVs produced from garlic may trigger apoptotic cell death in cancer cells while having no effect on healthy cells. Conclusion: It was discovered that plant SEVs had anti -cancer effects by activating caspase-mediated apoptosis.
  • Öğe
    MiR-29a-laden extracellular vesicles efficiently induced apoptosis through autophagy blockage in HCC cells
    (Elsevier B.V., 2024) Seydi, Homeyra; Nouri, Kosar; Shokouhian, Bahare; Piryaei, Abbas; Hassan, Moustapha; Cordani, Marco; Zarrabi, Ali; Shekari, Faezeh; Vosough, Massoud
    Background: In spite of significant advancements in theraputic modalities for hepatocellular carcinoma (HCC), there is still a high annual mortality rate with a rising incidence. Major challenges in the HCC clinical managment are related to the development of therapy resistance, and evasion of tumor cells apoptosis which leading unsatisfactory outcomes in HCC patients. Previous investigations have shown that autophagy plays crucial role in contributing to drug resistance development in HCC. Although, miR-29a is known to counteract authophagy, increasing evidence revealed a down-regulation of miR-29a in HCC patients which correlates with poor prognosis. Beside, evidences showed that miR-29a serves as a negative regulator of autophagy in other cancers. In the current study, we aim to investigate the impact of miR-29a on the autophagy and apoptosis in HCC cells using extracellular vesicles (EVs) as a natural delivery system given their potential in the miRNA delivery both in vitro and in vivo. Method: Human Wharton's Jelly mesenchymal stromal cell-derived extracellular vesicles were lately isolated through 20,000 or 110,000 × g centrifugation (EV20K or EV110K, respectively), characterized by western blot (WB), scanning electron microscopy (SEM), and dynamic light scattering (DLS). miR-29a was subsequently loaded into these EVs and its loading efficiency was evaluated via RT-qPCR. Comprehensive in vitro and in vivo assessments were then performed on Huh-7 and HepG2 cell lines. Results: EV20K-miR-29a treatment significantly induces cell apoptosis and reduces both cell proliferation and colony formation in Huh-7 and HepG2 cell lines. In addition, LC3-II/LC3-I ratio was increased while the expression of key autophagy regulators TFEB and ATG9A were downregulated by this treatment. These findings suggest an effective blockade of autophagy by EV20K-miR-29a leading to apoptosis in the HCC cell lines through concomitant targeting of critical mediators within each pathway. © 2024 Elsevier B.V.
  • Öğe
    Amine-functionalized mesoporous silica nanoparticles decorated by silver nanoparticles for delivery of doxorubicin in breast and cervical cancer cells
    (Elsevier, 2024) Ghobadi, Melika; Salehi, Saeideh; Ardestani, Mohammad Taha Salmanifard; Mousavi-Khattat, Mohammad; Shakeran, Zahra; Khosravi, Arezoo; Cordani, Marco; Zarrabi, Ali
    Nanocarriers have demonstrated promising potential in the delivery of various anticancer drugs and in improving the efficiency of the treatment. In this study, silver nanoparticles (AgNPs) were green-synthesized using the extracts of different parts of the pomegranate plant, including the peel, flower petals, and calyx. To obtain the most efficient extract used for the green synthesis of AgNPs, all three types of synthesized nanoparticles were characterized. Then, (3-Aminopropyl) triethoxysilane-functionalized mesoporous silica nanoparticles (MSNs-APTES) decorated with AgNPs were fabricated via a one-pot green-synthesis method. AgNPs were directly coated on the surface of MSNs-APTES by adding pomegranate extract enriched with a source of reducing agent leading to converting the silver ion to AgNPs. The MSN-APTES-AgNPs (MSNs-AgNPs) have been thoroughly characterized using nanoparticle characterization techniques. In addition, DNA cleavage and hemolysis activities of the synthesized nanoparticles were analyzed, confirming the biocompatibility of synthesized nanoparticles. The Doxorubicin (DOX, as a breast/cervical anti-cancer drug) loading (42.8%) and release profiles were investigated via UV-visible spectroscopy. The fibroblast, breast cancer, and cervical cancer cells' viability against DOX-loaded nanoparticles were also studied. The results of this high drug loading, uniform shape, and small functionalized nanoparticles demonstrated its great potential for breast and cervical cancer management.
  • Öğe
    Advancing personalized medicine: Integrating statistical algorithms with omics and nano-omics for enhanced diagnostic accuracy and treatment efficacy
    (Elsevier, 2024) Coşkun, Abdurrahman; Ertaylan, Gökhan; Pusparum, Murih; Van Hoof, Rebekka; Kaya, Zelal Zuhal; Khosravi, Arezoo; Zarrabi, Ali
    Medical laboratory services enable precise measurement of thousands of biomolecules and have become an inseparable part of high-quality healthcare services, exerting a profound influence on global health outcomes. The integration of omics technologies into laboratory medicine has transformed healthcare, enabling personalized treatments and interventions based on individuals' distinct genetic and metabolic profiles. Interpreting laboratory data relies on reliable reference values. Presently, population-derived references are used for individuals, risking misinterpretation due to population heterogeneity, and leading to medical errors. Thus, personalized references are crucial for precise interpretation of individual laboratory results, and the interpretation of omics data should be based on individualized reference values. We reviewed recent advancements in personalized laboratory medicine, focusing on personalized omics, and discussed strategies for implementing personalized statistical approaches in omics technologies to improve global health and concluded that personalized statistical algorithms for interpretation of omics data have great potential to enhance global health. Finally, we demonstrated that the convergence of nanotechnology and omics sciences is transforming personalized laboratory medicine by providing unparalleled diagnostic precision and innovative therapeutic strategies.
  • Öğe
    Carboxymethyl cellulose/sodium alginate hydrogel with anti-inflammatory capabilities for accelerated wound healing; In vitro and in vivo study
    (Elsevier, 2024) Hosseini, Seyed Mohammad Reza; Heydari, Parisa; Namnabat, Mahtab; Azadani, Reyhaneh Nasr; Gharibdousti, Fateme Azimi; Rizi, Elmira Mousavi; Khosravi, Arezoo; Zarepour, Atefeh; Zarrabi, Ali
    Recently, managing the chronic skin wounds has become increasingly challenging for healthcare professionals due to the intricate orchestration of cellular and molecular processes involved that lead to the uncontrollable inflammatory reactions which hinder the healing process. Therefore, different types of wound dressings with immunomodulatory properties have been developed in recent years to effectively regulate the immune responses, enhance angiogenesis, promote re-epithelialization, and accelerate the wound healing process. This study aims to develop a new type of immunomodulatory wound dressing utilizing carboxymethyl cellulose (CMC)/sodium alginate (Alg)-simvastatin (SIM) to simultaneously enhance the inflammatory responses and the wound healing ratio. The CMC/Alg-SIM hydrogels exhibited appropriate swelling ratio, water vapor transmission rate, and desirable degradation rate, depending on the SIM content. The fabricated dressing showed sustained release of SIM (during 5 days) that improved the proliferation of skin cells. According to the in vitro findings, the CMC/Alg-SIM hydrogel exhibited controlled pro-inflammatory responses (decreased 2.5- and 1.6-times IL-6 and TNF-alpha, respectively) and improved secretion of anti-inflammatory cytokines (increased 1.5- and 1.3-times IL-10 and TGF-beta, respectively) in comparison with CMC/Alg. Furthermore, the CMC/Alg-SIM hydrogel facilitated rapid wound healing in the rat model with a full-thickness skin defect. After 14 days post-surgery, the wound healing ratio in the CMC/Alg hydrogel group (-93%) was significantly greater than the control group (-58%). Therefore, the engineered CMC/Alg-SIM hydrogel with desired immunomodulatory properties possesses the potential to enhance and accelerate skin regeneration for the management of chronic wound healing.
  • Öğe
    The therapeutic efficacy of 5-ALA based photodynamic therapy and chemotherapy combination in triple negative breast cancer cells
    (Springer, 2024) Erk, Beyzanur; Kamanlı, Ali Furkan; Eskiler, Gamze Güney
    Triple negative breast cancer (TNBC) is one of the subtypes of breast cancer characterized by a heterogeneous and aggressive nature. Photodynamic therapy (PDT) has drawn significant attention in cancer treatment. However, solubility of photosensitizer, penetration problems into a target tissue and insufficient oxygen concentration limit the effectiveness of PDT. To overcome these limitations and to reduce the side effects of chemotherapy, combination treatment modalities play an essential role in cancer treatment. In this study, we aimed to investigate the combination efficacy of cisplatin-based chemotherapy and 5-Aminolevulinic acid (5-ALA)/PDT in TNBC cells and healthy breast cells in vitro. To determine the effect of the combination effects of cisplatin and 5-ALA/PDT on TNBC cells, two treatment protocols (simultaneous and sequential combination therapy) were evaluated compared with cisplatin and 5-ALA/PDT monotherapy and WST-1, Annexin V assay, acridine orange (AO) and mitochondrial staining were performed. Our findings showed that MDA-MB-231 TNBC cell viability was significantly decreased following simultaneous combination treatment compared to cisplatin and 5-ALA/PDT monotherapy. Additionally, simultaneous combination treatment was more effective than sequential combination treatment. The simultaneous combination treatment of 2.5 mu M cisplatin and 5-ALA/PDT at 6 J/cm2 and 9 J/cm2 induced 46.78% and 53.6% total apoptotic death, respectively in TNBC cells compared with monotherapies (cisplatin (37.88%) and 5-ALA/PDT (6 J/cm2: 31.48% and 9 J/cm2: 37.78%). Additionally, cisplatin and 5-ALA/PDT combination treatment resulted in nuclear fragmentation and mitochondrial damage due to apoptosis. Our results suggest that cisplatin and 5-ALA/PDT simultaneous combination therapy could be a promising new alternative strategy for treating TNBC. However, further studies are required to assess the underlying molecular mechanisms of cisplatin and 5-ALA/PDT combination treatment at the molecular level.
  • Öğe
    Robust electroencephalogram-based biometric identification against GAN-generated artificial signals using a novel end-to-end attention-based CNN-LSTM neural network
    (Springer, 2025) Zarean, Javad; Tajally, AmirReza; Tavakkoli-Moghaddam, Reza; Kia, Reza
    Electroencephalogram (EEG) signals, which exhibit dynamic properties and discriminative information among individuals, have recently been employed to develop human biometric identification and authentication systems. Despite the increasing interest in EEG-based human identification, the state-of-the-art still needs high-accuracy and easy-to-use systems in real-life applications. To improve the accuracy, robustness, and user-friendliness of EEG-based human identification systems, this paper presents a novel attention-based convolutional-long short-term memory network for EEG-based human biometric identification (ABCL-EHBI), which is robust against artificial EEG signals generated by generative adversarial networks (GANs). The proposed system uses an attention mechanism along with convolutional neural networks (CNNs) and long short-term memories (LSTMs) layers, leading to more effective exploitation of the raw EEG signals' spatial and temporal discriminative characteristics compared to a simple CNN-LSTM (CL) system. The system was evaluated and validated using the PhysioNet motor imagery dataset, which incorporates EEG signals of 109 individuals performing six various tasks. Experimental results show that the proposed approach achieves F1-Score accuracy of 99.65, 99.64, and 99.55 under the condition of using 64, 14, and only 9 EEG channels, respectively, which is better than the performance of EEG-based human identification in the previous studies. The fact that the proposed approach receives raw EEG signals as input without any need for feature extraction (end-to-end), shows high accuracy when using a small number of EEG channels and yields high accuracy against artificial EEG signals, making it reliable and easy to deploy in real-life applications.
  • Öğe
    Anionic polysaccharides as delivery carriers for cancer therapy and theranostics: An overview of significance
    (Elsevier b.v., 2025) Sivakumar, Ponnurengam Malliappan; Zarepour, Atefeh; Akhter, Sohail; Perumal, Govindaraj; Khosravi, Arezoo; Balasekar, Premkumar; Zarrabi, Ali
    Recently, cancer therapy has witnessed remarkable advancements with a growing focus on precision medicine and targeted drug delivery strategies. The application of anionic polysaccharides has gained traction in various drug delivery systems. Anionic polysaccharides have emerged as promising delivery carriers in cancer therapy and theranostics, offering numerous advantages such as biocompatibility, low toxicity, and the ability to encapsulate and deliver therapeutic agents to tumor sites with high specificity. This review underscores the significance of anionic polysaccharides as essential components of the evolving landscape of cancer therapy and theranostics. These polymers can be tailored to carry a wide range of therapeutic cargo, including chemotherapeutic agents, nucleic acids, and imaging agents. Their negative charge enables electrostatic interactions with positively charged drugs and facilitates the formation of stable nanoparticles, liposomes, or hydrogels for controlled drug release. Additionally, their hydrophilic nature aids in prolonging circulation time, reducing drug degradation, and minimizing off-target effects. Besides, some of them could act as targeting agents or therapeutic compounds that lead to improved therapeutic performance. This review offers valuable information for researchers, clinicians, and biomedical engineers. It provides insights into the recent progress in the applications of anionic polysaccharide-based delivery platforms in cancer theranostics to transform patient outcomes.
  • Öğe
    Alginate-based nanocomposite incorporating chitosan nanoparticles: A dual-drug delivery system for infection control and wound regeneration
    (Editions de sante, 2025) Mousavi, Seyed Javad; Heydari, Parisa; Javaherchi, Pouya; Kharazi, Anoushe Zargar; Zarrabi, Ali
    In this study, a hydrogel-based nanocomposite was fabricated as a novel wound dressing and drug delivery system. Initially, insulin-loaded chitosan nanoparticles (CSNP-INS) were produced using the ionic gelation technique. Subsequently, the CSNP-INS were introduced into ciprofloxacin-loaded sodium alginate (SA-Cip) hydrogel at two different concentrations (0.5 % and 1 % w/v), followed by crosslinking with CaCl2 after freezedrying to enhance its physical and biological properties. The CSNP-INS nanoparticles had an average size of 173.6 f 1.76 nm and effectively encapsulated 70 % of the INS. Physicochemical characterization revealed that SA-Cip/1%CSNP-INS has significant swelling (2996 f 31.55 %) and high hydrophilicity (16.94 f 0.99 degrees), along with slow degradation due to the electrostatic interaction between CSNP and SA hydrogel (80 % weight loss after 14 days). Moreover, the mechanical properties were enhanced due to the higher concentration of CSNP (83 f 1.9 kPa), with a Young's modulus of 83 f 1.9 kPa. The release profile of INS after incorporation of CSNP-INS into the hydrogel was slower and more sustained. On the other hand, Cip showed a burst release (100 % within 6 h). In vitro assays of the fabricated hydrogels on fibroblastic cells demonstrated high cell viability, enhanced cell migration, and complete in-vitro wound closure (100 % within 24 h). Further analysis of the inflammatory response of hydrogels revealed a significant impact on modulating inflammation markers including a decrease in TNF-alpha and an increase in TGF-beta. Cip and INS facilitate different wound-healing stages, ensuring efficient and accelerated wound healing. This study underscores the potential of the developed hydrogel as groundbreaking wound dressing, offering enhanced wound healing capabilities through an innovative mechanism of controlled and sustained drug release.
  • Öğe
    A novel microbial fuel cell design as biosensor to evaluate biochemical oxygen demand
    (Elsevier ltd, 2025) Naghibi, Negin; Khaleghi, Moj; Ataei, Seyed Ahmad; Zarrabi, Ali
    Microbial fuel cell (MFC) technology has gained significant attention for its dual capability to generate renewable energy and treat wastewater. Beyond these applications, MFCs have emerged as a promising tool for biosensing, particularly for detecting water pollutants. In this study, we aimed to optimize the evaluation of biochemical oxygen demand (BOD) by correlating it with the output voltage of an MFC. The effects of pH and external resistance on the MFC's performance were also assessed to enhance its operational stability. The experiment utilized a two-chambered MFC with a 2500 mL capacity, ceramic membrane, and carbon cloth electrodes. Synthetic wastewater and Shewanella xiamensis (code SH1 MF663195) were used as the anolyte, while distilled water served as the catholyte. Over 7 weeks, the MFC achieved a maximum current density of 1.939 mA/m2 and a power density of 80 mW/m2 at near-neutral pH and 3 k Omega external resistance. A positive linear correlation (R2 = 0.9984) was established between the output voltage and BOD concentration (16-436 mg/L). These findings suggest that this MFC-based biosensor is highly feasible and holds significant potential for real-time water quality monitoring.
  • Öğe
    Bacterial nanocelluloses as sustainable biomaterials for advanced wound healing and dressings
    (Royal Society of Chemistry, 2024) Zarepour, Atefeh; Gök, Bahar; Budama Kılınç, Yasemin; Khosravi, Arezoo; Iravani, Siavash; Zarrabi, Ali
    Wound healing remains a significant clinical challenge, calling for innovative approaches to expedite the recovery process and improve patient outcomes. Bacterial nanocelluloses (BNCs) have emerged as a promising solution in the field of wound healing and dressings due to their unique properties such as high crystallinity, mechanical strength, high purity, porosity, high water absorption capacity, biodegradability, biocompatibility, sustainability, and flexibility. BNC-based materials can be applied for the treatment of different types of wounds, from second-degree burns to skin tears, biopsy sites, and diabetic and ischemic wounds. BNC-based dressings have exceptional mechanical properties such as flexibility and strength, which ensure proper wound coverage and protection. The renewable nature, eco-friendly production process, longer lifespan, and potential for biodegradability of BNCs make them a more sustainable alternative to conventional wound care materials. This review aims to provide a detailed overview on the application of BNC-based composites for wound healing and dressings via highlighting their ability as a carrier for delivery of different types of antimicrobial compounds as well as their direct effect on the healing process. Besides, it mentions some of the in vivo and clinical studies using BNC-based dressings and describes challenges related to the application of these materials as well as their future directions. © 2024 The Royal Society of Chemistry.
  • Öğe
    Synergistic enhancement of osteogenesis: silica nanoparticles and proanthocyanidin on bioinspired nanofibrous scaffolds for craniofacial bone regeneration
    (Springer Nature, 2024) Galefi, Atena; Hosseini, Saadi; Alipour, Atefeh; Banaeyan, Rezvaneh; Farrokhi, Naser; Amanzadeh, Amir; Wang, Peng-Yuan; Zarrabi, Ali; Shahsavarani, Hosein
    The reconstruction of craniofacial bone defects is a significant challenge in regenerative medicine due to the limitations of standard grafts. In this study, we developed innovative, multifunctional, nanostructured scaffolds derived from Phlomis Monocephala leaves to address this issue. These fibrous cellulose scaffolds were coated with Grape Seed Proanthocyanidin Extract and Silica Nanoparticles, individually and in combination, to enhance their properties for bone tissue engineering applications. The scaffolds were meticulously evaluated for their morphology, chemical composition, swelling behavior, protein adsorption, hydrophilicity, porosity, and their ability to support cell survival, proliferation, and differentiation into bone cells. The scaffolds functionalized with both Grape Seed Proanthocyanidin Extract and Silica Nanoparticles exhibited the most favorable properties, significantly promoting the differentiation of human bone marrow mesenchymal stem cells into osteogenic cells. This was evidenced by increased alkaline phosphatase activity, matrix mineralization, collagen formation, and the expression of genes related to bone formation. Additionally, these nanostructured scaffolds demonstrated superior antibacterial activity against both Gram-positive and Gram-negative bacteria compared to uncoated scaffolds. In vivo biocompatibility assessments revealed that the Grape Seed Proanthocyanidin Extract and Silica Nanoparticles-coated scaffolds performed excellently in terms of re-epithelialization, vascularization, and reducing inflammation, showcasing their potential for future clinical applications. Our findings highlight the immense potential of these nanostructured scaffolds as biocompatible materials for treating bone tissue defects, offering a novel and effective approach in the field of nanotechnology and regenerative medicine. © Qatar University and Springer Nature Switzerland AG 2024.